Fulvestrant Injection, Solution
Product Images NDC 63323-715
Product Visual Gallery
This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Fulvestrant (NDC 63323-715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Ful04 0007 02)
Figure 3 (Ful04 0007 03)
Figure 4 (Ful04 0007 04)
Structural Formula (Ful04 0007 05)
Figure 6 (Ful04 0007 06)
Figure 7 (Ful04 0007 07)
Figure 8 (Ful04 0007 08)
Figure 9 (Ful04 0007 09)
Figure 10 (Ful04 0007 10)
Figure 11 (Ful04 0007 11)
Figure 12 (Ful04 0007 12)
Figure 13 (Ful04 0007 13)
Figure 14 (Ful04 0007 14)
Fresenius Kabi Logo (Ful04 0007 15)
Fresenius Kabi Logo (Ful04 0007 16)
Principal Display Panel – Fulvestrant Injection 250 mg Per 5 mL Syringe Carton Panel (Ful04 0007 17)
Principal Display Panel – Fulvestrant Injection 250 mg Per 5 mL Syringe Label (Ful04 0007 18)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.